menu
    • menu

    Company profile for Veloxis Pharmaceuticals

    NEW Drugs in Dev: 6
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, is a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patients. A Danish company, Veloxis Pharmaceuticals A/S operates in the U.S. through Veloxis Pharmaceuticals Inc., a wholly-owned subsidiary headquartered in Cary, North Carolina, USA. Veloxis has successfully developed ENVARSUS XR (tacrolimus extended-release tablets...
    Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, is a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patients. A Danish company, Veloxis Pharmaceuticals A/S operates in the U.S. through Veloxis Pharmaceuticals Inc., a wholly-owned subsidiary headquartered in Cary, North Carolina, USA. Veloxis has successfully developed ENVARSUS XR (tacrolimus extended-release tablets) based upon the company’s unique and patented delivery technology, MeltDose®, which is designed to enhance the absorption and bioavailability of select orally administered drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Veloxis PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1001 Winstead Drive, Cary, NC 27513
    Telephone
    Telephone
    1 919 591 3090
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.panpharma.eu/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/panpharma/?originalSubdomain=fr
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    German Wound Congress

    German Wound Congress

    Not Confirmed

    envelop Contact Supplier

    German Wound Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OSE Welcomes FDA Orphan Drug Tag for Heart Transplant Drug
    OSE Welcomes FDA Orphan Drug Tag for Heart Transplant Drug

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281280/0/en/ose-immunotherapeutics-welcomes-fda-orphan-drug-designation-granted-to-pegrizeprument-vel-101-for-prevention-of-organ-rejection-in-heart-transplant-patients.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Pegrizeprument Secures Orphan Status in Heart Transplant
    Pegrizeprument Secures Orphan Status in Heart Transplant

    22 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pegrizeprument-granted-orphan-drug-designation-for-prevention-of-organ-rejection-in-heart-transplant-patients-302749183.html

    PR NEWSWIRE
    22 Apr 2026
    Share Share
    Asahi Kasei to buy Germany's Aicuris for $920M
    Asahi Kasei to buy Germany's Aicuris for $920M

    27 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/asahi-kasei-accrue-german-aicuris-920-million-rd-portfolio-boost

    FIERCE BIOTECH
    27 Feb 2026
    Share Share
    OSE Immunotherapeutics Welcomes FDA Orphan Designation
    OSE Immunotherapeutics Welcomes FDA Orphan Designation

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3223109/0/en/OSE-Immunotherapeutics-Welcomes-FDA-Orphan-Drug-Designation-Granted-to-Pegrizeprument-VEL-101.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    Pegrizeprument Receives Orphan Drug Status For Liver Transplant
    Pegrizeprument Receives Orphan Drug Status For Liver Transplant

    21 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pegrizeprument-granted-orphan-drug-designation-for-prevention-of-organ-rejection-in-patients-receiving-a-liver-transplant-302666801.html

    PR NEWSWIRE
    21 Jan 2026
    Share Share
    Veloxis Pharmaceuticals Presenting at 2025 Transplant Congress
    Veloxis Pharmaceuticals Presenting at 2025 Transplant Congress

    30 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/veloxis-pharmaceuticals-to-present-at-2025-world-transplant-congress-302516650.html

    PR NEWSWIRE
    30 Jul 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search